The estimated Net Worth of Judy C Lewent is at least $17.2 million dollars as of 10 June 2013. Ms. Lewent owns over 15,000 units of Thermo Fisher Scientific stock worth over $16,814,690 and over the last 21 years she sold TMO stock worth over $0. In addition, she makes $351,177 as Independent Director at Thermo Fisher Scientific.
Judy has made over 2 trades of the Thermo Fisher Scientific stock since 2013, according to the Form 4 filled with the SEC. Most recently she exercised 15,000 units of TMO stock worth $876,000 on 10 June 2013.
The largest trade she's ever made was exercising 15,000 units of Thermo Fisher Scientific stock on 10 June 2013 worth over $876,000. On average, Judy trades about 463 units every 3 days since 2003. As of 10 June 2013 she still owns at least 27,188 units of Thermo Fisher Scientific stock.
You can see the complete history of Ms. Lewent stock trades at the bottom of the page.
Judy C. Lewent is Independent Director of the Company. Ms. Lewent’s nearly 20 years in executive management roles at Merck & Co., Inc., a global pharmaceutical company, enables her to bring valuable experience in a highly regulated industry to the Board. With her experience as the former Chief Financial Officer and Executive Vice President of Merck, Ms. Lewent brings financial acumen and expertise, strategic leadership skills and international experience to the Board. Ms. Lewent also brings valuable board-level experience from her many years served on public company boards, including her service on various committees, such as the Audit, Nominating and Corporate Governance, Remuneration, Risk, and Science Committees.
As the Independent Director of Thermo Fisher Scientific, the total compensation of Judy Lewent at Thermo Fisher Scientific is $351,177. There are 12 executives at Thermo Fisher Scientific getting paid more, with Marc Casper having the highest compensation of $19,023,100.
Judy Lewent is 71, she's been the Independent Director of Thermo Fisher Scientific since 2008. There are no older and 25 younger executives at Thermo Fisher Scientific.
Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler et Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Thermo Fisher Scientific executives and other stock owners filed with the SEC include: